therefore determined the incidence of VOD using the McDonald's criteria and analyzed the clinical characteristics of patients with VOD and those without it. One hundred and thirty-seven consecutive patients who received bone marrow or peripheral blood stem cell transplantation were studied retrospectively to identify the risk factors for hepatic veno-occlusive disease Materials and methods (VOD). Of the 137 recipients, twenty (14.6%) patients were diagnosed with VOD using the McDonald's criPatients teria. In these 20 patients with VOD, we analyzed various clinical parameters, including age, sex, HLA status, One hundred and thirty-seven consecutive patients (52 conditioning regimen, irradiation, immunosuppressive males and 85 females) underwent bone marrow transplanagents, mode of transplantation, history of hepatic dystation (including peripheral blood transplantation) for function, pre-transplant hepatic and renal function, hematological malignancies and severe aplastic anemia at infectious episodes, antibiotics use, and serum viral titour institution between September 1989 and October 1995.
total lymphoid irradiation (TLI), 7.0 Gy in two fractions. and the mortality rate is high. Various parameters have
All patients who underwent allogeneic transplantation been reported as risk factors; history of liver dysfunction, received acute GVHD prophylaxis as follows: short-term elevated AST levels before transplantation, transplantation MTX and cyclosporine (CsA) (81 patients), CsA alone (22 from an HLA-mismatched or unrelated donor, abdominal patients), FK-506 and short-term MTX (three patients) and irradiation, previous fungal infection, and various chemo-FK506 alone (one patient). therapeutic agents. [3] [4] [5] We cannot reliably identify a high risk group of VOD before transplantation and reliable therapy and prophylaxis have not been established.
Diagnosis of VOD The objective of this paper was to determine the risk factors for VOD and to select the high risk patients. We
Patients were diagnosed as having VOD using the McDonald's criteria. were defined as having a positive history of hepatic dysfunction.
Factors
No.
Results of laboratory tests performed around day −30 were defined as the pretransplant levels. the risk factors with the multiple logistic regression analysis MDS 10 was then added to the appropriate variables. 
Risk factors for VOD
Univariate analysis was performed with various parameters. ing therapy. Hepatomegaly and ascites were diagnosed A significant difference was not observed using the variclinically and/or radiologically. ables in our study apart from a history of hepatic dysfunction and low levels of pretransplant pseudocholinesterase Risk factors (Tables 3 and 4 ). In our analysis, previously reported risk factors including abdominal irradiation, unrelated BMT, Risk factors for VOD were determined by comparing the and fungal infection were not statistically significant. [2] [3] [4] [5] patients with and without VOD. Risk factors included age, We added the logistic regression analysis for further sex, HLA status, conditioning regimen, irradiation, evaluation. No significant difference was observed except immunosuppressive agents, nature of transplant (allogeneic, for levels of pseudocholinesterase. This remained a signifiautologous or syngeneic, related or unrelated), hepatic and cant risk factor by this evaluation (P = 0.02). The odds ratio renal function before transplantation, infectious episodes, was 4.42 per 100 IU/l of pseudocholinesterase. Distribution antibiotics use, serum viral titers (EB virus, herpes simplex of pseudocholinesterase levels in patients with or without virus, cytomegalovirus (CMV), adenovirus).
VOD is shown in Figure 1 . This result suggests that patients In analyzing viral infection, patients with complement with low levels of pretransplant pseudocholinesterase have fixation titers higher than ×4 were regarded as positive. a high risk for VOD. The patients who received bone marrow from a oneWe evaluated long-term survival in patients with VOD. locus or more mismatched donor or who received it from Figure 2 shows the results of the Kaplan-Meier analysis an unrelated donor were regarded as mismatched recipients.
with the log-rank test. It is apparent that the patients with Use of antibiotics was limited to intravenous adminis-VOD have a poorer prognosis than those without VOD. tration from day −7 to day 30, and oral prophylaxis was omitted from our analysis.
We defined both total body irradiation (TBI) and total Discussion lymphoid irradiation (TLI) as irradiation, and local irradiation performed to control extramedullary leukemic infiltration was not included in the analysis.
The incidence of VOD was 14.6% by the McDonald's criteria, comparable to the values previously reported. 6 We Patients with a history of hepatitis, liver dysfunction, positive hepatitis virus antibody, maximum AST and/or excluded four cases which had clinical characteristics of VOD, but with a distinct cause other than VOD: three cases ALT level of more than 100 IU/l, or maximum total bilirubin level of more than 1.5 mg/dl during the previous year of acute GVHD and one case of congestive heart failure. One patient presented with hepatomegaly, body weight gain impossible to evaluate a history of liver dysfunction accurately in a retrospective fashion. and jaundice after day 20. His clinical features satisfied the McDonald's criteria for VOD in the absence of other causes Our analysis disclosed one more important risk factor: pseudocholinesterase levels a generic term which includes of hepatotoxicity. According to the McDonald's criteria, he was not diagnosed as having VOD; however, the onset of various enzymes that hydrolyze a cholinester into choline and organic acid. 12 This enzyme level correlates with pro-VOD may have been late, a situation which has recently been advocated. 7 tein synthesis in the liver and with the number of functional hepatocytes. The relation between incidence of VOD and Our evaluation demonstrated a lower survival rate for patients with VOD than for those without it (Figure 2) . this enzyme level is unknown. However, hepatic VOD may more commonly develop in a liver with latent dysfuncBoth survival curves showed a plateau. This is probably due to the early mortality in patients with VOD. In analyztion. 13, 14 For this reason, we added pseudocholinesterase levels to the analysis of risk factors for hepatic VOD. ing the long-term survival in patients who had survived more than 100 days, the difference in outcome disappeared Serum AST, ALT and ALP levels mirror the extent of hepatic injury and are not necessarily proportional to hepatic (data not shown, P = 0.46). In our analysis, seven out of 20 patients with VOD died. Three died of hepatic failure reserve. This is the first report to demonstrate a correlation between VOD and decreased levels of pseudocholinesterase (including VOD). These three patients died at days 87, 122, and 228 after BMT, respectively. Other causes were relapse before BMT. The level of this enzyme differed between the patients with VOD and without it to an extent which was (two cases), cerebral bleeding and infection (one case of each).
statistically significant on univariate analysis (Table 4) . Furthermore, multivariate analysis with logistic Some pilot studies have suggested the effectiveness of heparin 8 and ursodiol 9 for prophylaxis of VOD. However, regression also revealed levels of this enzyme to be statistically significant (P = 0.02). Figure 1 shows the distribution a recent randomized trial denied the efficacy of heparin. 10 To make prophylaxis effective, reliable selection of high of pseudocholinesterase levels in patients with or without VOD. This result may indicate that patients with poor heprisk patients is necessary. For this purpose, accurate information about the etiology and risk factors for VOD are atic reserve will be even more severely damaged by conditioning therapy and that they will more readily manifest required.
Univariate analysis showed two parameters to be statistiascites, jaundice and weight gain. Among the various parameters which reflect hepatic cally significant: a history of hepatic dysfunction and low levels of pseudocholinesterase before transplantation function, we consider pseudocholinesterase levels to be the most reliable indicator of hepatic reserve before BMT. (Tables 3 and 4) . The former has often been reported as an important risk factor for VOD. 1, 9, 11 However, the definition Other hepatic enzymes such as AST, ALT and ALP are influenced by transient liver pathology and may correlate of hepatic dysfunction has differed in each study, and it is poorly with clinical outcome. Other parameters such as It is well known that this enzyme decreases transiently during and after chemotherapy. A short interval from the coagulation tests, total cholesterol and albumin, which reflect the relatively short term ability of the liver to syntheend of previous chemotherapy to the start of conditioning may be a risk factor of VOD. However, among patients size protein, had a tendency to be lower in the patients with VOD, but this was not statistically significant.
with VOD, only one had had chemotherapy during the luronate acid levels may be appropriate, since these enzymes reflect other aspects of liver function.
In conclusion, retrospective analysis revealed that a low month prior to BMT, and this patient underwent BMT in relapse. In our analysis, chemotherapy just before BMT level of pseudocholinesterase is a risk factor for VOD. This suggests that poor hepatic reserve plays an important role seemed to have little effect on pseudocholinesterase levels.
For further evaluation of VOD, evaluation of antithromin the etiology of VOD and that pseudocholinesterase levels reflect it most accurately. bin III, 15 type IV collagen, type III procollagen 16, 17 and hya-
